Versant Venture Capital VI, L.P., 10% Owner at LENZ Therapeutics, Inc. (LENZ), sold 521,426 shares at $39.50 ($20.5M) on 2025-08-15, disclosed to the SEC on 2025-08-19.
Open-market sale of $20.5M LENZ by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.50 | 69,949 | $2.8M | 13.5% |
| 2 | $39.50 | 69,949 | $2.8M | 13.5% |
| 3 | $39.50 | 145,051 | $5.7M | 27.9% |
| 4 | $39.50 | 145,051 | $5.7M | 27.9% |
| 5 | $38.56 | 15,085 | $582K | 2.8% |
| 6 | $38.56 | 15,085 |
| $582K |
| 2.8% |
| 7 | $38.56 | 30,628 | $1.2M | 5.8% |
| 8 | $38.56 | 30,628 | $1.2M | 5.8% |
| Total | $39.34 avg | 521,426 | $20.5M | 100% |
| Filing → |
| GLUE | SELL | 2024-09-24 | $14.8M | — | Filing → |
| TPST | SELL | 2024-08-12 | $1.4M | — | Filing → |
| OYST | SELL | 2021-10-20 | $16.3M | — | Filing → |